Search Tag: personalised medicine
2015 16 Jan
New research from Montreal Heart Institute (MHI) has found that cardiovascular patients with a specific genetic profile benefit greatly from the new medication dalcetrapib. The drug reduced heart attacks, strokes, unstable angina, coronary revascularisations and cardiovascular deaths by as much as 39 percent. The findings could pave the way for a new...Read more